← Back to Explore

The "Smart" Cancer Drug: Targeting Cancer's Achilles Heel with Novel CRISPR/Cas9

ISEF · 2016 First Award

Overview

Development of cancer-specific drugs is critical to improve quality of life and survival of cancer patients. This integrative research demonstrates a novel concept to improve specificity of cancer treatments by targeting Warburg Effect using conditional, or cell type-specific, CRISPR/Cas9. Cancer cells heavily depend on glycolysis (Warburg Effect); thus, blocking glycolysis may preferentially kill cancer cells, sparing normal cells. Warburg Effect can be targeted by disrupting key glycolysis gene, ENO1, using state-of-the-art gene editing technology, CRISPR/Cas9. Therefore, knocking out ENO1 by CRISPR/Cas9 activated in a cancer-specific manner is hypothesized to selectively kill cancer cells. Here, HEK293 and A549 cells were used as a model system to determine if conditional CRISPR/Cas9-mediated inactivation of ENO1 leads to cell type-specific toxicity. Bioinformatics analysis revealed highly expressed genes in HEK293 or A549. Subsequently, promoters of those genes were used to create HEK293- and A549-specific CRISPR/Cas9 vectors designed to inactivate ENO1 in a cell type-specific manner. Indeed, MiSeq sequence analysis revealed that HEK293- and A549-specific CRISPR/Cas9 preferentially generated knockout mutations in ENO1. Furthermore, conditional CRISPR/Cas9 induced significant and selective toxicity in HEK293 and A549 as evidenced by MTS and trypan blue assays (p<0.05). Significant reduction of ENO1 protein, lactic acid, and ATP production in a cell type-specific fashion were also observed, providing molecular insights into conditional CRISPR/Cas9-generated cell type-specific toxicity. Taken together, these data unequivocally demonstrate the power of the novel strategy of cancer-specific CRISPR/Cas9 to significantly increase the selectivity of cancer therapeutics.

Awards (2)

  • First Award of $5,000 $5,000
  • Intel ISEF Best of Category Award of $5,000 $5,000

Competition history

  • ISEF 2016 Category not listed · Entry BMED037

Resources

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Source: Regeneron International Science and Engineering Fair

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. Browsing stays public.

Continue with Google